Global Cell Dissociation Research Report 2023: Asia-Pacific Emerges as the Fastest-Growing Market for Cell Dissociation with High R&D Investments and Favorable Regulations

DUBLIN, July 26, 2023 /PRNewswire/ -- The "Global Cell Dissociation Market by Product (Trypsin, Papain, DNase, Hyaluronidase, Instruments), Tissue Type (Connective Tissue, Epithelial Tissue), End-user (Pharma, Biopharma, Research Institutes) & Region - Forecast to 2028" report has been added to  ResearchAndMarkets.com's offering.

The global cell dissociation market is projected to grow from USD 600 million in 2023 to USD 1.4 billion by 2028 at a CAGR of 17.8%

The key factors driving the growth of the cell dissociation market are the increase in recombinant therapeutics sourced from mammalian cells, the growing focus on personalized medicine, and increasing GMP certification approvals for cell therapy production facilities. Additionally, advancements in non-enzymatic tissue dissociation are expected to offer lucrative market opportunities.

This report studies the cell dissociation market based on product, tissue type, application, end-user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.

The report also studies micro-markets with respect to their growth trends, prospects, and contributions to the total cell dissociation market. The report forecasts the revenue of the market segments with respect to four major regions.

Enzymatic dissociation products segment to witness the highest growth during the forecast period

Based on product, the cell dissociation market is segmented into enzymatic dissociation agents, non-enzymatic dissociation agents, and instruments & accessories.

The enzymatic dissociation agents segment dominated the cell dissociation market in 2022. It is expected to hold the largest share till 2028. The expanding pool of operational entities in this segment and established protocols for using enzymatic dissociation agents are key contributors to market growth.

Non-enzymatic alternatives for cell dissociation are being developed to overcome the limitations of traditional enzymes. Instruments and accessories form a niche segment, with few manufacturers active.

Connective tissue segment to register the highest growth in the cell dissociation market during the forecast period

Based on tissue type, the cell dissociation market has been segmented into connective tissue, epithelial tissue, and other tissues (muscle tissue, lung tissue, and nerve tissue). Connective tissue dominated the cell dissociation market in 2022. The extensive research on connective tissues has ensured a high share of this segment. However, the epithelial tissue segment is expected to grow at the highest rate over the forecast period.

Asia-Pacific is estimated to register the highest CAGR during the forecast period

The Asia-Pacific market is estimated to register the highest growth during the forecast period primarily due to the rising R&D investments in the pharmaceutical sectors of several emerging APAC countries, favorable regulatory guidelines & government support, lower manufacturing costs, and increasing incidence of diseases.

Competitive landscape

The prominent players in the global cell dissociation market are Merck KGaA (Germany), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Corning Incorporated (US), Becton, Dickinson and Company (US), STEMCELL Technologies (Canada), PromoCell GmbH (Germany), Miltenyi Biotec (Germany), ATCC (US), HiMedia Laboratories (India), and Genlantis, Inc. (US).

Market Dynamics

Drivers

• Increase in Recombinant Therapeutics Sourced from Mammalian Cells
• Growing Focus on Personalized Medicine
• CGMP Approvals for New Cell Therapy Production Facilities

Restraints

• High Cost of Cell-based Research

Opportunities

• Advancements in Non-Enzymatic Tissue Dissociation

Challenges

• Limitations Associated with Dissociated Cell Culture

Company Profiles

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• Cytiva (Danaher Corporation)
• Becton, Dickinson and Company
• Corning Inc.
• Promocell GmbH
• Miltenyi Biotec
• ATCC
• HiMedia Laboratories
• Pan-Biotech
• CellSystems GmbH
• AMSBio
• Neuromics
• Other Players
• Vitacyte
• Alstembio
• Biological Industries (Sartorius)
• Geminibio
• Innovative Cell Technologies, Inc.
• Central Drug House (P) Ltd.
• Worthington Biochemical Corporation
• Capricorn Scientific
• Abeomics
• Genlantis

For more information about this report visit https://www.researchandmarkets.com/r/l3uhrs

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets